Malin Wendt

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Mass Spectrometry

Top Venues

Cancer medicine

Acta oto-laryngologica

This page only lists publications with an associated author ORCID identifier.

Publications

Rusana Bark, Aeneas Kolev, Alexandra Elliot, Krzysztof Piersiala, Anders Näsman, Per Grybäck, Susanna Kumlien Georén, Malin Wendt, Lars-Olaf Cardell, Gregori Margolin, Linda Marklund
Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment. Cancer medicine (2023)
Rusana Bark, Aeneas Kolev, Alexandra Elliot, Krzysztof Piersiala, Anders Näsman, Per Grybäck, Susanna Kumlien Georén, Malin Wendt, Lars-Olaf Cardell, Gregori Margolin, Linda Marklund
Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment. Cancer medicine (2023)
Rusana Bark, Aeneas Kolev, Alexandra Elliot, Krzysztof Piersiala, Anders Näsman, Per Grybäck, Susanna Kumlien Georén, Malin Wendt, Lars-Olaf Cardell, Gregori Margolin, Linda Marklund
Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment. Cancer medicine (2023)
Rusana Bark, Aeneas Kolev, Alexandra Elliot, Krzysztof Piersiala, Anders Näsman, Per Grybäck, Susanna Kumlien Georén, Malin Wendt, Lars-Olaf Cardell, Gregori Margolin, Linda Marklund
Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment. Cancer medicine (2023)
Malin Wendt, Georgios Papatziamos, Eva Munck-Wikland, Linda Marklund
Sclerotherapy of ranulas with OK-432 - a prospective, randomized, double-blinded placebo-controlled study. Acta oto-laryngologica 141 (5) (2021)
Malin Wendt, Lalle Hammarstedt-Nordenvall, Mark Zupancic, Signe Friesland, David Landin, Eva Munck-Wikland, Tina Dalianis, Anders Näsman, Linda Marklund
Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status. Cancers 13 (11) (2021)